FISH analysis was utilized to detect BCR-ABL fusions among 15 cases out of 30 BM samples (13 suspected CML patients and two CML patients under imatinib therapy), and the results showed BCR-ABL fusions in 5 out of 13 patients. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.